speb/financial-data huggingface dataset:
CBRS cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 11537000.00
CBRS income_statement (annual, 2024-12-31) — Diluted Average Shares: 207533000.00
CBRS income_statement (annual, 2024-12-31) — Diluted EPS: -2.68
CBRS income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -484784000.00
CBRS income_statement (annual, 2024-12-31) — EBIT: -101639000.00
CBRS income_statement (annual, 2024-12-31) — EBITDA: -90102000.00
CBRS cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -304000.00
CBRS cash_flow (annual, 2024-12-31) — End Cash Position: 581965000.00
CBRS balance_sheet (annual, 2024-12-31) — Financial Assets: 0.00
CBRS balance_sheet (quarterly, 2024-12-31) — Financial Assets: 0.00
CBRS cash_flow (annual, 2024-12-31) — Financing Cash Flow: 112296000.00
CBRS balance_sheet (annual, 2024-12-31) — Finished Goods: 59486000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Finished Goods: 59486000.00
CBRS cash_flow (annual, 2024-12-31) — Free Cash Flow: 428543000.00
CBRS cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 401264000.00
CBRS income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -401264000.00
CBRS balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 220000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 220000.00
CBRS income_statement (annual, 2024-12-31) — General And Administrative Expense: 53685000.00
CBRS balance_sheet (annual, 2024-12-31) — Gross PPE: 102960000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Gross PPE: 102960000.00
CBRS income_statement (annual, 2024-12-31) — Gross Profit: 122738000.00
CBRS balance_sheet (annual, 2024-12-31) — Hedging Assets Current: 0.00
CBRS balance_sheet (quarterly, 2024-12-31) — Hedging Assets Current: 0.00
CBRS cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 258000.00
CBRS income_statement (annual, 2024-12-31) — Interest Income: 23228000.00
CBRS income_statement (annual, 2024-12-31) — Interest Income Non Operating: 23228000.00
CBRS balance_sheet (annual, 2024-12-31) — Inventory: 174492000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Inventory: 174492000.00
CBRS balance_sheet (annual, 2024-12-31) — Invested Capital: -966791000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Invested Capital: -966791000.00
CBRS cash_flow (annual, 2024-12-31) — Investing Cash Flow: -16785000.00
CBRS cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 85000000.00
CBRS balance_sheet (annual, 2024-12-31) — Leases: 3950000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Leases: 3950000.00
CBRS balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 27370000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 27370000.00
CBRS balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 27370000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 27370000.00
CBRS balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 54664000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 54664000.00
CBRS cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
CBRS income_statement (annual, 2024-12-31) — Net Income: -481602000.00
CBRS income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -484784000.00
CBRS income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -481602000.00
CBRS income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -481602000.00
CBRS income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -481602000.00
CBRS cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -481602000.00
CBRS income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -481602000.00
CBRS income_statement (annual, 2024-12-31) — Net Interest Income: 23228000.00
CBRS cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 6650000.00
CBRS income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 23228000.00
CBRS cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -326000.00
CBRS balance_sheet (annual, 2024-12-31) — Net PPE: 79745000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Net PPE: 79745000.00
CBRS cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -23435000.00
CBRS cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 84898000.00
CBRS balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -966791000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: -966791000.00
CBRS balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 18885000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 18885000.00
CBRS balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 18885000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 18885000.00
CBRS income_statement (annual, 2024-12-31) — Normalized EBITDA: 311162000.00
CBRS income_statement (annual, 2024-12-31) — Normalized Income: -164603440.00
CBRS cash_flow (annual, 2024-12-31) — Operating Cash Flow: 451978000.00
CBRS cash_flow (annual, 2024-12-31) — Operating Gains Losses: 401264000.00
CBRS income_statement (annual, 2024-12-31) — Operating Income: -101639000.00
CBRS income_statement (annual, 2024-12-31) — Operating Revenue: 290252000.00
CBRS balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 215110345.00
CBRS balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 215110345.00
CBRS balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 365122000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 365122000.00
CBRS balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 220000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 220000.00
CBRS income_statement (annual, 2024-12-31) — Other Gand A: 37439000.00
CBRS income_statement (annual, 2024-12-31) — Other Income Expense: -401264000.00
CBRS cash_flow (annual, 2024-12-31) — Other Non Cash Items: 6219000.00
CBRS balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 2514000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 2514000.00
CBRS balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 5073000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 5073000.00
CBRS income_statement (annual, 2024-12-31) — Other Operating Expenses: 201000.00
CBRS balance_sheet (annual, 2024-12-31) — Other Properties: 36571000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Other Properties: 36571000.00
CBRS balance_sheet (annual, 2024-12-31) — Other Receivables: 12718000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Other Receivables: 12718000.00
CBRS balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 116943000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 116943000.00
CBRS income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
CBRS balance_sheet (annual, 2024-12-31) — Payables: 27580000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Payables: 27580000.00
CBRS balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 86008000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 86008000.00
CBRS balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 17805000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 17805000.00
CBRS balance_sheet (annual, 2024-12-31) — Preferred Securities Outside Stock Equity: 850066000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Preferred Securities Outside Stock Equity: 850066000.00
CBRS income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 3182000.00
CBRS cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 85000000.00
CBRS cash_flow (annual, 2024-12-31) — Preferred Stock Payments: -102000.00
CBRS balance_sheet (annual, 2024-12-31) — Prepaid Assets: 6461000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 6461000.00
CBRS income_statement (annual, 2024-12-31) — Pretax Income: -479675000.00
CBRS cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 27724000.00
CBRS balance_sheet (annual, 2024-12-31) — Properties: 0.00
CBRS balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CBRS cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 12525000.00
CBRS cash_flow (annual, 2024-12-31) — Purchase Of Investment: -302898000.00
CBRS cash_flow (annual, 2024-12-31) — Purchase Of PPE: -23435000.00
CBRS balance_sheet (annual, 2024-12-31) — Raw Materials: 77168000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Raw Materials: 77168000.00
CBRS balance_sheet (annual, 2024-12-31) — Receivables: 150618000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Receivables: 150618000.00
CBRS income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 167514000.00
CBRS income_statement (annual, 2024-12-31) — Reconciled Depreciation: 11537000.00
CBRS cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -102000.00
CBRS income_statement (annual, 2024-12-31) — Research And Development: 158234000.00
CBRS balance_sheet (annual, 2024-12-31) — Restricted Cash: 361757000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 361757000.00
CBRS balance_sheet (annual, 2024-12-31) — Retained Earnings: -1143157000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -1143157000.00
CBRS income_statement (annual, 2024-12-31) — Salaries And Wages: 16246000.00
CBRS cash_flow (annual, 2024-12-31) — Sale Of Investment: 309548000.00
CBRS income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 12257000.00
CBRS income_statement (annual, 2024-12-31) — Selling General And Administration: 65942000.00
CBRS balance_sheet (annual, 2024-12-31) — Share Issued: 215110345.00
CBRS balance_sheet (quarterly, 2024-12-31) — Share Issued: 215110345.00
CBRS cash_flow (annual, 2024-12-31) — Stock Based Compensation: 58564000.00
CBRS balance_sheet (annual, 2024-12-31) — Stockholders Equity: -966791000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: -966791000.00
CBRS balance_sheet (annual, 2024-12-31) — Tangible Book Value: -966791000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: -966791000.00
CBRS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -84265440.00
CBRS income_statement (annual, 2024-12-31) — Tax Provision: 1927000.00
CBRS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
CBRS balance_sheet (annual, 2024-12-31) — Taxes Receivable: 464000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 464000.00
CBRS balance_sheet (annual, 2024-12-31) — Total Assets: 1112738000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Total Assets: 1112738000.00
CBRS balance_sheet (annual, 2024-12-31) — Total Capitalization: -966791000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Total Capitalization: -966791000.00
CBRS balance_sheet (annual, 2024-12-31) — Total Debt: 40673000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Total Debt: 40673000.00
CBRS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -966791000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: -966791000.00
CBRS income_statement (annual, 2024-12-31) — Total Expenses: 391891000.00
CBRS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 2079529000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 2079529000.00
CBRS balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 82259000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 82259000.00
CBRS balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 901394000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 901394000.00
CBRS income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -101438000.00
CBRS balance_sheet (annual, 2024-12-31) — Total Tax Payable: 1950000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 1950000.00
CBRS income_statement (annual, 2024-12-31) — Total Unusual Items: -401264000.00
CBRS income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -401264000.00
CBRS balance_sheet (annual, 2024-12-31) — Treasury Stock: 88000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 88000.00
CBRS balance_sheet (annual, 2024-12-31) — Work In Process: 37838000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Work In Process: 37838000.00
CBRS balance_sheet (annual, 2024-12-31) — Working Capital: -147656000.00
CBRS balance_sheet (quarterly, 2024-12-31) — Working Capital: -147656000.00
CBRS income_statement (quarterly, 2025-03-31) — +Operating Expense: 70284000.00
CBRS income_statement (quarterly, 2025-03-31) — +Total Revenue: 99512000.00
CBRS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 180819000.00
CBRS income_statement (quarterly, 2025-03-31) — Basic EPS: -0.13
CBRS cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 581965000.00
CBRS cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -98244000.00
CBRS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 1552000.00
CBRS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -56746000.00
CBRS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -54937000.00
CBRS cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -5650000.00
CBRS cash_flow (quarterly, 2025-03-31) — Change In Inventory: 53752000.00
CBRS cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -15326000.00
CBRS cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -144544000.00
CBRS cash_flow (quarterly, 2025-03-31) — Change In Payable: -5650000.00
CBRS cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -5650000.00
CBRS cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 3688000.00
CBRS cash_flow (quarterly, 2025-03-31) — Change In Receivables: 56787000.00
CBRS cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -51293000.00
CBRS cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 56787000.00
CBRS cash_flow (quarterly, 2025-03-31) — Changes In Cash: -110131000.00
CBRS cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
CBRS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 57908000.00
CBRS cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 3911000.00
CBRS cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 3911000.00
CBRS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 207533000.00
CBRS income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.13
CBRS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -23867000.00
CBRS income_statement (quarterly, 2025-03-31) — EBIT: -22184000.00
CBRS income_statement (quarterly, 2025-03-31) — EBITDA: -18273000.00
CBRS cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 180000.00
CBRS cash_flow (quarterly, 2025-03-31) — End Cash Position: 472014000.00
CBRS cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 1552000.00
CBRS cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -153181000.00
CBRS income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 6997000.00
CBRS income_statement (quarterly, 2025-03-31) — Gross Profit: 41604000.00
CBRS income_statement (quarterly, 2025-03-31) — Interest Expense: 0.00
CBRS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 0.00
CBRS income_statement (quarterly, 2025-03-31) — Interest Income: 6496000.00
CBRS income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 6496000.00
CBRS cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -56746000.00
CBRS cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
CBRS cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
CBRS cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
CBRS income_statement (quarterly, 2025-03-31) — Net Income: -23867000.00
CBRS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -23867000.00
CBRS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -23867000.00
CBRS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -23867000.00
CBRS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -23867000.00
CBRS cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -23867000.00
CBRS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -23867000.00
CBRS income_statement (quarterly, 2025-03-31) — Net Interest Income: 6496000.00
CBRS cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 41498000.00
CBRS cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
CBRS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 6496000.00
CBRS cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -98244000.00
CBRS cash_flow (quarterly, 2025-03-31) — Net Preferred Stock Issuance: 0.00
CBRS cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 0.00
CBRS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -18273000.00
CBRS income_statement (quarterly, 2025-03-31) — Normalized Income: -23867000.00
CBRS cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -54937000.00
CBRS income_statement (quarterly, 2025-03-31) — Operating Income: -28680000.00
CBRS income_statement (quarterly, 2025-03-31) — Operating Revenue: 99512000.00
CBRS income_statement (quarterly, 2025-03-31) — Other Gand A: 6997000.00
CBRS cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 2658000.00
CBRS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 210000.00
CBRS cash_flow (quarterly, 2025-03-31) — Preferred Stock Issuance: 0.00
CBRS cash_flow (quarterly, 2025-03-31) — Preferred Stock Payments: 0.00
CBRS income_statement (quarterly, 2025-03-31) — Pretax Income: -22184000.00
CBRS cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 1552000.00
CBRS cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 4500000.00
CBRS cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -20175000.00
CBRS cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -98244000.00
CBRS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 57908000.00
CBRS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 3911000.00
CBRS cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
CBRS income_statement (quarterly, 2025-03-31) — Research And Development: 52751000.00
CBRS cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 61673000.00
CBRS income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 10326000.00
CBRS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 17323000.00
CBRS cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 0.00
CBRS cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 9154000.00
CBRS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CBRS income_statement (quarterly, 2025-03-31) — Tax Provision: 1683000.00
CBRS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
CBRS income_statement (quarterly, 2025-03-31) — Total Expenses: 128192000.00
CBRS income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -28470000.00
CBRS income_statement (annual, 2025-12-31) — +Operating Expense: 344325000.00
CBRS income_statement (annual, 2025-12-31) — +Total Revenue: 509991000.00
CBRS balance_sheet (annual, 2025-12-31) — Accounts Payable: 48630000.00
CBRS balance_sheet (annual, 2025-12-31) — Accounts Receivable: 50423000.00
CBRS balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -51194000.00
CBRS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 346829000.00
CBRS income_statement (annual, 2025-12-31) — Basic Average Shares: 180819000.00
CBRS income_statement (annual, 2025-12-31) — Basic EPS: 0.48
CBRS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 581965000.00
CBRS cash_flow (annual, 2025-12-31) — Capital Expenditure: -382739000.00
CBRS balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 261822000.00
CBRS balance_sheet (annual, 2025-12-31) — Capital Stock: 1000.00
CBRS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 701706000.00
CBRS balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1108237000.00
CBRS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 1026560000.00
CBRS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -667576000.00
CBRS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -10050000.00
CBRS cash_flow (annual, 2025-12-31) — Change In Account Payable: 21151000.00
CBRS cash_flow (annual, 2025-12-31) — Change In Inventory: 63307000.00
CBRS cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 3141000.00
CBRS cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -176383000.00
CBRS cash_flow (annual, 2025-12-31) — Change In Payable: 21151000.00
CBRS cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 21151000.00
CBRS cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -13867000.00
CBRS cash_flow (annual, 2025-12-31) — Change In Receivables: 87012000.00
CBRS cash_flow (annual, 2025-12-31) — Change In Working Capital: -15639000.00
CBRS cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 87012000.00
CBRS cash_flow (annual, 2025-12-31) — Changes In Cash: 348934000.00
CBRS balance_sheet (annual, 2025-12-31) — Common Stock: 1000.00
CBRS balance_sheet (annual, 2025-12-31) — Common Stock Equity: -578655000.00
CBRS cash_flow (annual, 2025-12-31) — Common Stock Payments: -21368000.00
CBRS balance_sheet (annual, 2025-12-31) — Construction In Progress: 163451000.00
CBRS income_statement (annual, 2025-12-31) — Cost Of Revenue: 310920000.00
CBRS balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 59458000.00
CBRS balance_sheet (annual, 2025-12-31) — Current Assets: 1543646000.00
CBRS balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 45865000.00
CBRS balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 45865000.00
CBRS balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 485509000.00
CBRS balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 485509000.00
CBRS balance_sheet (annual, 2025-12-31) — Current Liabilities: 719540000.00
CBRS balance_sheet (annual, 2025-12-31) — Current Provisions: 9368000.00
CBRS cash_flow (annual, 2025-12-31) — Depreciation: 34454000.00
CBRS cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 34454000.00
CBRS cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 34454000.00
CBRS income_statement (annual, 2025-12-31) — Diluted Average Shares: 207533000.00
CBRS income_statement (annual, 2025-12-31) — Diluted EPS: 0.42
CBRS income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 87875000.00
CBRS income_statement (annual, 2025-12-31) — EBIT: -145254000.00
CBRS income_statement (annual, 2025-12-31) — EBITDA: -110800000.00
CBRS cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -521000.00
CBRS cash_flow (annual, 2025-12-31) — End Cash Position: 930378000.00
CBRS balance_sheet (annual, 2025-12-31) — Financial Assets: 91447000.00
CBRS cash_flow (annual, 2025-12-31) — Financing Cash Flow: 1026560000.00
CBRS balance_sheet (annual, 2025-12-31) — Finished Goods: 36719000.00
CBRS cash_flow (annual, 2025-12-31) — Free Cash Flow: -392789000.00
CBRS cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -363336000.00
CBRS income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 363336000.00
CBRS balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 1301000.00
CBRS income_statement (annual, 2025-12-31) — General And Administrative Expense: 40919000.00
CBRS balance_sheet (annual, 2025-12-31) — Gross PPE: 737540000.00
CBRS income_statement (annual, 2025-12-31) — Gross Profit: 199071000.00
CBRS balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 60906000.00
CBRS cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 1699000.00
CBRS income_statement (annual, 2025-12-31) — Interest Income: 26802000.00
CBRS income_statement (annual, 2025-12-31) — Interest Income Non Operating: 26802000.00
CBRS balance_sheet (annual, 2025-12-31) — Inventory: 63626000.00
CBRS balance_sheet (annual, 2025-12-31) — Invested Capital: -578655000.00
CBRS cash_flow (annual, 2025-12-31) — Investing Cash Flow: -667576000.00
CBRS cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 1100000000.00
CBRS balance_sheet (annual, 2025-12-31) — Leases: 22348000.00
CBRS balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 215957000.00
CBRS balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 215957000.00
CBRS balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 302791000.00
CBRS cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -21368000.00
CBRS income_statement (annual, 2025-12-31) — Net Income: 237827000.00
CBRS income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 87875000.00
CBRS income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 237827000.00
CBRS income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 237827000.00
CBRS income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 237827000.00
CBRS cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 237827000.00
CBRS income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 237827000.00
CBRS income_statement (annual, 2025-12-31) — Net Interest Income: 26802000.00
CBRS cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -284837000.00
CBRS income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 26802000.00
CBRS cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -3305000.00
CBRS balance_sheet (annual, 2025-12-31) — Net PPE: 686346000.00
CBRS cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -382739000.00
CBRS cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 1083282000.00
CBRS balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -578655000.00
CBRS balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 35847000.00
CBRS balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 35847000.00
CBRS income_statement (annual, 2025-12-31) — Normalized EBITDA: -474136000.00
CBRS income_statement (annual, 2025-12-31) — Normalized Income: -115081256.80
CBRS cash_flow (annual, 2025-12-31) — Operating Cash Flow: -10050000.00
CBRS cash_flow (annual, 2025-12-31) — Operating Gains Losses: -363336000.00
CBRS income_statement (annual, 2025-12-31) — Operating Income: -145254000.00
CBRS income_statement (annual, 2025-12-31) — Operating Revenue: 509991000.00
CBRS balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 215110345.00
CBRS balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 13335000.00
CBRS balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 1301000.00
CBRS income_statement (annual, 2025-12-31) — Other Gand A: 24133000.00
CBRS income_statement (annual, 2025-12-31) — Other Income Expense: 363336000.00
CBRS cash_flow (annual, 2025-12-31) — Other Non Cash Items: 25908000.00
CBRS balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 4598000.00
CBRS income_statement (annual, 2025-12-31) — Other Operating Expenses: -608000.00
CBRS balance_sheet (annual, 2025-12-31) — Other Properties: 248950000.00
CBRS balance_sheet (annual, 2025-12-31) — Other Receivables: 18791000.00
CBRS balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 406531000.00
CBRS income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 149952000.00
CBRS balance_sheet (annual, 2025-12-31) — Payables: 84207000.00
CBRS balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 143665000.00
CBRS balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 21798000.00
CBRS balance_sheet (annual, 2025-12-31) — Preferred Securities Outside Stock Equity: 1933348000.00
CBRS cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 1100000000.00
CBRS cash_flow (annual, 2025-12-31) — Preferred Stock Payments: -16718000.00
CBRS balance_sheet (annual, 2025-12-31) — Prepaid Assets: 8196000.00
CBRS income_statement (annual, 2025-12-31) — Pretax Income: 244884000.00
CBRS cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: -32049000.00
CBRS balance_sheet (annual, 2025-12-31) — Properties: 0.00
CBRS cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 20969000.00
CBRS cash_flow (annual, 2025-12-31) — Purchase Of Investment: -525414000.00
CBRS cash_flow (annual, 2025-12-31) — Purchase Of PPE: -382739000.00
CBRS balance_sheet (annual, 2025-12-31) — Raw Materials: 15939000.00
CBRS balance_sheet (annual, 2025-12-31) — Receivables: 74009000.00
CBRS income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 310920000.00
CBRS income_statement (annual, 2025-12-31) — Reconciled Depreciation: 34454000.00
CBRS cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -38086000.00
CBRS income_statement (annual, 2025-12-31) — Research And Development: 243319000.00
CBRS balance_sheet (annual, 2025-12-31) — Restricted Cash: 228672000.00
CBRS balance_sheet (annual, 2025-12-31) — Retained Earnings: -905330000.00
CBRS income_statement (annual, 2025-12-31) — Salaries And Wages: 16786000.00
CBRS cash_flow (annual, 2025-12-31) — Sale Of Investment: 240577000.00
CBRS income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 60695000.00
CBRS income_statement (annual, 2025-12-31) — Selling General And Administration: 101614000.00
CBRS balance_sheet (annual, 2025-12-31) — Share Issued: 215110345.00
CBRS cash_flow (annual, 2025-12-31) — Stock Based Compensation: 49767000.00
CBRS balance_sheet (annual, 2025-12-31) — Stockholders Equity: -578655000.00
CBRS balance_sheet (annual, 2025-12-31) — Tangible Book Value: -578655000.00
CBRS income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 10427743.20
CBRS income_statement (annual, 2025-12-31) — Tax Provision: 7057000.00
CBRS income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.03
CBRS balance_sheet (annual, 2025-12-31) — Taxes Receivable: 4795000.00
CBRS balance_sheet (annual, 2025-12-31) — Total Assets: 2326037000.00
CBRS balance_sheet (annual, 2025-12-31) — Total Capitalization: -578655000.00
CBRS balance_sheet (annual, 2025-12-31) — Total Debt: 261822000.00
CBRS balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -578655000.00
CBRS income_statement (annual, 2025-12-31) — Total Expenses: 655245000.00
CBRS balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 2904692000.00
CBRS balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 782391000.00
CBRS balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2185152000.00
CBRS income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -145862000.00
CBRS balance_sheet (annual, 2025-12-31) — Total Tax Payable: 35577000.00
CBRS income_statement (annual, 2025-12-31) — Total Unusual Items: 363336000.00
CBRS income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 363336000.00
CBRS balance_sheet (annual, 2025-12-31) — Treasury Stock: 21456000.00
CBRS balance_sheet (annual, 2025-12-31) — Work In Process: 10968000.00
CBRS balance_sheet (annual, 2025-12-31) — Working Capital: 824106000.00
CBRS income_statement (quarterly, 2026-03-31) — +Operating Expense: 102468000.00
CBRS income_statement (quarterly, 2026-03-31) — +Total Revenue: 193406000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 50336000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 62631000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -67043000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 742713000.00
CBRS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 215110345.00
CBRS income_statement (quarterly, 2026-03-31) — Basic EPS: -0.07
CBRS cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 930378000.00
CBRS cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -131970000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 378692000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1716016000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2231621000.00
CBRS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 2038106000.00
CBRS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -236616000.00
CBRS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 12335000.00
CBRS cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -10070000.00
CBRS cash_flow (quarterly, 2026-03-31) — Change In Inventory: -21684000.00
CBRS cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 8995000.00
CBRS cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 50735000.00
CBRS cash_flow (quarterly, 2026-03-31) — Change In Payable: -10070000.00
CBRS cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -10070000.00
CBRS cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -57603000.00
CBRS cash_flow (quarterly, 2026-03-31) — Change In Receivables: -12208000.00
CBRS cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -41835000.00
CBRS cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -12208000.00
CBRS cash_flow (quarterly, 2026-03-31) — Changes In Cash: 1813825000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Common Stock: 1000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -194682000.00
CBRS cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 15019000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 294664000.00
CBRS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 107230000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 103929000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Current Assets: 3580961000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 66218000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Current Debt: 621306000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 687524000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 518344000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 518344000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1427246000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 10934000.00
CBRS cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 18175000.00
CBRS cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 18175000.00
CBRS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 215110345.00
CBRS income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.07
CBRS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -14006000.00
CBRS income_statement (quarterly, 2026-03-31) — EBIT: 6440000.00
CBRS income_statement (quarterly, 2026-03-31) — EBITDA: 24615000.00
CBRS cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 911000.00
CBRS cash_flow (quarterly, 2026-03-31) — End Cash Position: 2745114000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Financial Assets: 425355000.00
CBRS cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 2038106000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 69969000.00
CBRS cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -119635000.00
CBRS cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 2053000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 3396000.00
CBRS income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 11017000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 992785000.00
CBRS income_statement (quarterly, 2026-03-31) — Gross Profit: 86176000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 90701000.00
CBRS cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 574000.00
CBRS income_statement (quarterly, 2026-03-31) — Interest Expense: 18949000.00
CBRS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 18949000.00
CBRS income_statement (quarterly, 2026-03-31) — Interest Income: 22732000.00
CBRS income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 22732000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Inventory: 89040000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 788241000.00
CBRS cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -236616000.00
CBRS cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 1029268000.00
CBRS cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 1004571000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Leases: 22701000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 312474000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 361617000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 674091000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 322117000.00
CBRS cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 15019000.00
CBRS income_statement (quarterly, 2026-03-31) — Net Income: -14006000.00
CBRS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -14006000.00
CBRS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -14006000.00
CBRS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -14006000.00
CBRS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -14006000.00
CBRS cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -14006000.00
CBRS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -14006000.00
CBRS income_statement (quarterly, 2026-03-31) — Net Interest Income: 3783000.00
CBRS cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -104646000.00
CBRS cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 1004571000.00
CBRS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 3783000.00
CBRS cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -830000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Net PPE: 925742000.00
CBRS cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -131970000.00
CBRS cash_flow (quarterly, 2026-03-31) — Net Preferred Stock Issuance: 1014031000.00
CBRS cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 1004571000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -194682000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 94344000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 94344000.00
CBRS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 24615000.00
CBRS income_statement (quarterly, 2026-03-31) — Normalized Income: -14006000.00
CBRS cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 12335000.00
CBRS cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 2053000.00
CBRS income_statement (quarterly, 2026-03-31) — Operating Income: -16292000.00
CBRS income_statement (quarterly, 2026-03-31) — Operating Revenue: 193406000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 215110345.00
CBRS balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 621306000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 20876000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 3396000.00
CBRS income_statement (quarterly, 2026-03-31) — Other Gand A: 11017000.00
CBRS cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 33765000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 16320000.00
CBRS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 1255000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Other Properties: 353303000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 34281000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 515605000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Payables: 62067000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 165996000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 23572000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Preferred Securities Outside Stock Equity: 2947379000.00
CBRS cash_flow (quarterly, 2026-03-31) — Preferred Stock Issuance: 1014249000.00
CBRS cash_flow (quarterly, 2026-03-31) — Preferred Stock Payments: -218000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 37441000.00
CBRS income_statement (quarterly, 2026-03-31) — Pretax Income: -12509000.00
CBRS cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 5315000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
CBRS cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 4590000.00
CBRS cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -308801000.00
CBRS cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -131970000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 10032000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Receivables: 103060000.00
CBRS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 107230000.00
CBRS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 18175000.00
CBRS cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -218000.00
CBRS income_statement (quarterly, 2026-03-31) — Research And Development: 75495000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 1029098000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -919336000.00
CBRS cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 204155000.00
CBRS income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 14701000.00
CBRS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 25718000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Share Issued: 215110345.00
CBRS cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 1004571000.00
CBRS cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 9593000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -194682000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -194682000.00
CBRS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CBRS income_statement (quarterly, 2026-03-31) — Tax Provision: 1497000.00
CBRS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
CBRS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 6148000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Total Assets: 4948378000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 166935000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Total Debt: 1361615000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -194682000.00
CBRS income_statement (quarterly, 2026-03-31) — Total Expenses: 209698000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 5143060000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1367417000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 3715814000.00
CBRS income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -15037000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 11731000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 21456000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Work In Process: 9039000.00
CBRS balance_sheet (quarterly, 2026-03-31) — Working Capital: 2153715000.00
CBSAB.PA income_statement (annual, 2022-03-31) — +Operating Expense: 1850600.00
CBSAB.PA income_statement (annual, 2022-03-31) — +Total Revenue: 4280700.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Accounts Payable: 2559200.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Accounts Receivable: 440400.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 0.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Assets Held For Sale Current: 0.00
CBSAB.PA cash_flow (annual, 2022-03-31) — Capital Expenditure: -11026300.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 2252100.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Capital Stock: 24258800.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 2647200.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 2647200.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Cash Equivalents: 0.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Cash Financial: 2647200.00
CBSAB.PA cash_flow (annual, 2022-03-31) — Changes In Cash: 2610200.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Common Stock: 24258800.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Common Stock Equity: 17619000.00
CBSAB.PA income_statement (annual, 2022-03-31) — Cost Of Revenue: 487100.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Current Assets: 5916100.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 236500.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Current Debt: 0.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 236500.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Current Liabilities: 2908900.00
CBSAB.PA income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 3807000.00
CBSAB.PA income_statement (annual, 2022-03-31) — EBIT: 3987700.00
CBSAB.PA income_statement (annual, 2022-03-31) — EBITDA: 3987700.00
CBSAB.PA cash_flow (annual, 2022-03-31) — Financing Cash Flow: 22738300.00
CBSAB.PA cash_flow (annual, 2022-03-31) — Free Cash Flow: 1341500.00
CBSAB.PA income_statement (annual, 2022-03-31) — General And Administrative Expense: 749600.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Goodwill: 4195200.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 11014500.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 440400.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Gross PPE: 2248000.00
CBSAB.PA income_statement (annual, 2022-03-31) — Gross Profit: 3793600.00
CBSAB.PA income_statement (annual, 2022-03-31) — Interest Expense: 62200.00
CBSAB.PA income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 62200.00
CBSAB.PA cash_flow (annual, 2022-03-31) — Interest Paid Cff: -500.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Inventory: 2828500.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Invested Capital: 17619000.00
CBSAB.PA cash_flow (annual, 2022-03-31) — Investing Cash Flow: -21469600.00
CBSAB.PA balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 8144900.00